You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

MONISTAT-DERM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Monistat-derm, and when can generic versions of Monistat-derm launch?

Monistat-derm is a drug marketed by Insight Pharms and is included in two NDAs.

The generic ingredient in MONISTAT-DERM is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Monistat-derm

A generic version of MONISTAT-DERM was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MONISTAT-DERM?
  • What are the global sales for MONISTAT-DERM?
  • What is Average Wholesale Price for MONISTAT-DERM?
Summary for MONISTAT-DERM
Drug patent expirations by year for MONISTAT-DERM
Recent Clinical Trials for MONISTAT-DERM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital Central "Dr. Ignacio Morones Prieto"Phase 4
Universidad Autonoma de San Luis PotosíPhase 4

See all MONISTAT-DERM clinical trials

US Patents and Regulatory Information for MONISTAT-DERM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Insight Pharms MONISTAT-DERM miconazole nitrate CREAM;TOPICAL 017494-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Insight Pharms MONISTAT-DERM miconazole nitrate LOTION;TOPICAL 017739-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MONISTAT-DERM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Insight Pharms MONISTAT-DERM miconazole nitrate CREAM;TOPICAL 017494-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Insight Pharms MONISTAT-DERM miconazole nitrate LOTION;TOPICAL 017739-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Insight Pharms MONISTAT-DERM miconazole nitrate LOTION;TOPICAL 017739-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Insight Pharms MONISTAT-DERM miconazole nitrate CREAM;TOPICAL 017494-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MONISTAT-DERM

See the table below for patents covering MONISTAT-DERM around the world.

Country Patent Number Title Estimated Expiration
Czechoslovakia 184753 FUNGICIDAL AND BACTERICIDAL AGENT ⤷  Sign Up
Israel 32840 1-(BETA-ARYL-ETHYL)-IMIDAZOLE ETHERS AND AMINES ⤷  Sign Up
Netherlands 6912331 ⤷  Sign Up
Switzerland 532585 Procédé de fabrication de dérivés d'imidazole (Imidazole derivs antifungals and antibacterials) ⤷  Sign Up
Japan S51115 ⤷  Sign Up
Yugoslavia 34194 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.